{"id":"W2083342497","doi":"10.1001/jama.290.4.486","title":"Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance","year":2003,"lang":"en","type":"article","venue":"JAMA","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1623,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôtel-Dieu de Montréal; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Bayer","keywords":"Medicine; Acarbose; Impaired glucose tolerance; Internal medicine; Hazard ratio; Postprandial; Placebo; Heart failure; Diabetes mellitus; Body mass index; Randomized controlled trial; Surgery; Type 2 diabetes; Endocrinology; Insulin; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006003306144631211,"score_gpt":0.1812743189844947,"score_spread":0.1752710128398635,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}